ArticleJournal of physiology and biochemistry2026

Targeting canonical TGFβ/SMAD3 and ERK1/2 signaling in human valve interstitial cells to modulate immune-fibrotic responses in rheumatic heart disease.

Charan Sai Ramireddi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.